Tilarginine is a competitive inhibitor of nitric oxide synthetase. References: Firger J. Nitric Oxide Inhibitors Hit Target for Triple-Negative Breast Cancer. J Natl Cancer Inst. 2015 Aug 4;107(8). pii: djv235. doi: 10.1093/jnci/djv235. Print 2015 Aug. PubMed PMID: 26243205; PubMed Central PMCID: PMC4609569.
纯度:≥98%
CAS:17035-90-4